Maharashtra Eases Plastic Ban On Bottles But With Recycling Rider
Maharashtra decided to revoke the ban on plastic bottles, providing some relief from its earlier decision to curb environmental damage from the non-biodegradable material. But on one condition.
All manufacturers have to establish a recycling chain by setting up reverse vending machines and tie up with recyclers, a senior official from the environment ministry told BloombergQuint.
The state, the largest generator of plastic waste in India, had on March 23 banned use, purchase, sale, distribution and storage of single-use disposal plastic, items made from thermocol and polyethylene terephthalate and polyethylene terephthalate esters bottles of less than 0.5 litres. For other bottles, including those used for water and beverages, consumer have to pay more upfront and get refunds of up to Rs 2 on returning them at deposit centres.
Now, all bottles are included in the buyback scheme. The decision was taken after plastic bottles manufacturers' association met the environment minister.
“We urged the government to include plastic bags in the buyback scheme as well,” said Ravi Jashnani, president of Maharashtra Plastic Manufacturing Association. “The government didn't accept their demand.”
Also Read: Plastic Ban: Celebrate The Maharashtrian New Year With A New Mindset
The state also plans give consumers and traders more time before implementing the new norms, the official quoted above said. Instead of one month, manufacturers, retailers and traders will be given three months to dispose of the existing stock. Similarly, local bodies will be given three months, instead of one, to arrange collection and transportation and scientific disposal of banned plastic bottles.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.